Clinical trialNCT00534599CompletedPhase 3Interventional

Generalized Anxiety Disorder Adjunct Study

SponsorAstraZenecaEnrollment409AnxietyAnxiety DisordersAnxiety NeurosesAnxiety States

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Martin Brecher, MD
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

53 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Birmingham, Alabama, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Beverly Hills, California, United States
Research Site
Encino, California, United States
Research Site
Fresno, California, United States
Research Site
La Mesa, California, United States
Research Site
Oceanside, California, United States
Research Site
Redlands, California, United States
Research Site
San Diego, California, United States
Research Site
San Francisco, California, United States
Research Site
Sherman Oaks, California, United States
Research Site
Bradenton, Florida, United States
Research Site
Dayton, Florida, United States
Research Site
Hialeah, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Maitland, Florida, United States
Research Site
Miami, Florida, United States
Research Site
North Miami, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
West Palm Beach, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Columbus, Georgia, United States
Research Site
Chicago, Illinois, United States
Research Site
Lafayette, Indiana, United States
Research Site
Merrillville, Indiana, United States
Research Site
Terre Haute, Indiana, United States
Research Site
Prairie Village, Kansas, United States
Research Site
Owenboro, Kentucky, United States
Research Site
New Orleans, Louisiana, United States
Research Site
Rockville, Maryland, United States
Research Site
Boston, Massachusetts, United States
Research Site
Cherry Hill, New Jersey, United States
Research Site
Clementon, New Jersey, United States
Research Site
Brooklyn, New York, United States
Research Site
Cedarhurst, New York, United States
Research Site
Fresh Meadows, New York, United States
Research Site
New York, New York, United States
Research Site
Rochester, New York, United States
Research Site
Staten Island, New York, United States

13 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Aug 2007
Primary completion: 30 Sept 2008
Completion: 30 Sept 2008
Last update posted: 14 Apr 2011
Registered enrollment: 409
Registry id: NCT00534599

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.